Scenarios that move CI
The Cigna Group Common Stock
Scenarios that move CI: 13 analyses, 9 positive, 4 negative.
- · Opus Genetics receives FDA approval for presbyopia eye drop — ▲ · impact +5 · confidence low · horizon quarters
- · Mirum's Livmarli meets Phase III goal in ultra-rare liver diseases — ▼ · impact -10 · confidence low · horizon quarters
- · UnitedHealth tops estimates, raises profit outlook despite high medical costs — ▲ · impact +61 · confidence medium · horizon immediate
- · Hims & Hers faces securities fraud class action after FTC lawsuit — ▲ · impact +10 · confidence low · horizon quarters
- · Liquidia stock plunges 57% after UTHR patent setback — ▲ · impact +7 · confidence low · horizon quarters
- · United Therapeutics stock rises 12.6% in trading — ▲ · impact +15 · confidence low · horizon quarters
- · Novo Nordisk's Ozempic outperforms Lilly's Mounjaro on cardiovascular risk — ▲ · impact +31 · confidence medium · horizon quarters
- · DBV Technologies files FDA BLA for VIASKIN Peanut patch — ▲ · impact +8 · confidence low · horizon quarters
- · ◇ What if… Mitch McConnell steps down from Senate before term ends — ▼ · impact -45 · confidence low · horizon weeks
- · FDA approves Isembyld for spinal muscular atrophy treatment — ▲ · impact +9 · confidence low · horizon quarters
- · Amgen shares fall after Novartis' Pelacarsen misses Phase III goal — ▲ · impact +15 · confidence low · horizon quarters
- · ◇ What if… Major Cyberattack Disrupts Largest US Health Insurance Claims Processors Nationwide — ▼ · confidence medium
- · ◇ What if… Major Cyberattack Takes Down Two Largest US Health Insurance Claims Processors — ▼ · confidence medium